Ghosh; Soumitra S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ghosh; Soumitra S..The latest application filed is for "engineered polypeptides having enhanced duration of action".

Company Profile

0.48.75

Ghosh; Soumitra S. - San Diego CA
Ghosh; Soumitra S. - Cambridge MA
Ghosh; Soumitra S. - Wilmington DE US
Ghosh; Soumitra S - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered Polypeptides Having Enhanced Duration Of Action App 20200362006 - Erickson; Mary ; et al.	2020-11-19
Engineered Polypeptides Having Enhanced Duration Of Action With Reduced Immunogenicity App 20180344813 - ERICKSON; Mary ; et al.	2018-12-06
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity App 20180305430 - Erickson; Mary ; et al.	2018-10-25
Engineered polypeptides having enhanced duration of action and reduced immunogenicity Grant 9,879,063 - Erickson , et al. January 30, 2	2018-01-30
Engineered Polypeptides Having Enhanced Duration Of Action App 20170114114 - Erickson; Mary ; et al.	2017-04-27
Engineered polypeptides having enhanced duration of action Grant 9,593,154 - Erickson , et al. March 14, 2	2017-03-14
Hybrid polypeptides with selectable properties Grant 9,453,063 - Levy , et al. September 27, 2	2016-09-27
Engineered Polypeptides Having Enhanced Duration Of Action And Reduced Immunogenicity App 20160207974 - Erickson; Mary ; et al.	2016-07-21
Engineered polypeptides having enhanced duration of action with reduced immunogenicity Grant 9,382,304 - Erickson , et al. July 5, 2	2016-07-05
Engineered Polypeptides Having Enhanced Duration Of Action App 20160137709 - Erickson; Mary ; et al.	2016-05-19
C-terminal amidation of polypeptides Grant 9,249,181 - Sun , et al. February 2, 2	2016-02-02
GLP-1 receptor agonist compounds having stabilized regions Grant 9,217,022 - Alfaro-Lopez , et al. December 22, 2	2015-12-22
GIP analog and hybrid polypeptides with selectable properties Grant 9,133,260 - Levy , et al. September 15, 2	2015-09-15
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20150231204 - LEVY; Odile Esther ; et al.	2015-08-20
Site-specific Enzymatic Modification Of Exendins And Analogs Thereof App 20150111246 - Samant; Manoj P. ; et al.	2015-04-23
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20140371148 - GHOSH; Soumitra S. ; et al.	2014-12-18
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,906,849 - Levy , et al. December 9, 2	2014-12-09
Engineered Poypeptides Having Enhanced Duration Of Action And Reduced Immunogenicity App 20140256621 - Erickson; Mary ; et al.	2014-09-11
Hybrid Polypeptides With Selectable Properties App 20140249299 - Levy; Odile Esther ; et al.	2014-09-04
Engineered Polypeptides Having Enhanced Duration Of Action With Reduced Immunogenicity App 20140235535 - Erickson; Mary ; et al.	2014-08-21
Peptide-peptidase inhibitor conjugates and methods of using same Grant 8,759,295 - Ghosh , et al. June 24, 2	2014-06-24
N-terminus Conformationally Constrained Glp-1 Receptor Agonist Compounds App 20140162943 - ALFARO-LOPEZ; Josue ; et al.	2014-06-12
Engineered Polypeptides Having Enhanced Duration Of Action App 20140107019 - ERICKSON; Mary ; et al.	2014-04-17
Hybrid polypeptides with selectable properties Grant 8,697,647 - Levy , et al. April 15, 2	2014-04-15
Polypeptide Conjugate App 20140066370 - Forood; Behrouz Bruce ; et al.	2014-03-06
C-terminal Amidation Of Polypeptides App 20140058070 - Sun; Chengzao ; et al.	2014-02-27
N-terminus conformationally constrained GLP-1 receptor agonist compounds Grant 8,642,544 - Alfaro-Lopez , et al. February 4, 2	2014-02-04
Pancreatic polypeptide family motifs and polypeptides comprising the same Grant 8,603,969 - Levy , et al. December 10, 2	2013-12-10
Peptide-peptidase-inhibitor conjugates and methods of making and using same Grant 8,598,314 - Ghosh , et al. December 3, 2	2013-12-03
Methods for treatment using amylin family peptides Grant 8,598,120 - Soares , et al. December 3, 2	2013-12-03
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20130303442 - LEVY; Odile Esther ; et al.	2013-11-14
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties App 20130281374 - Levy; Odile Esther ; et al.	2013-10-24
Engineered Polypeptides Having Enhanced Duration Of Action App 20130274182 - Erickson; Mary ; et al.	2013-10-17
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130196913 - Levy; Odile Esther ; et al.	2013-08-01
DPP-IV resistant GIP hybrid polypeptides with selectable properties Grant 8,497,240 - Levy , et al. July 30, 2	2013-07-30
Glp-1 Receptor Agonist Compounds Having Stabilized Regions App 20130184203 - Alfaro-Lopez; Josue ; et al.	2013-07-18
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,426,361 - Levy , et al. April 23, 2	2013-04-23
GIP analog and hybrid polypeptides with selectable properties Grant 8,404,637 - Levy , et al. March 26, 2	2013-03-26
Hybrid Polypeptides With Selectable Properties App 20120253023 - LEVY; Odile Esther ; et al.	2012-10-04
GIP analog and hybrid polypeptides with selectable properties Grant 8,263,545 - Levy , et al. September 11, 2	2012-09-11
N-terminus Conformationally Constrained Glp-1 Receptor Agonist Compounds App 20120046222 - Alfaro-Lopez; Josue ; et al.	2012-02-23
Amylin family peptides Grant 8,114,958 - Soares , et al. February 14, 2	2012-02-14
Hybrid polypeptides having glucose lowering activity Grant 8,076,288 - Levy , et al. December 13, 2	2011-12-13
DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties App 20110136737 - Levy; Odile Esther ; et al.	2011-06-09
Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same App 20100292172 - GHOSH; SOUMITRA S. ; et al.	2010-11-18
Peptide-peptidase-inhibitor Conjugates And Methods Of Making And Using Same App 20100286365 - Ghosh; Soumitra S. ; et al.	2010-11-11
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 7,723,471 - Levy , et al. May 25, 2	2010-05-25
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20100099619 - Levy; Odile Esther ; et al.	2010-04-22
Composition and Methods for Treatment of Congestive Heart Failure App 20100029554 - Ghosh; Soumitra S. ; et al.	2010-02-04
Hybrid Polypeptides with Selectable Properties App 20090286723 - Levy; Odile Esther ; et al.	2009-11-19
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20090186817 - Ghosh; Soumitra S. ; et al.	2009-07-23
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20090036364 - Levy; Odile Esther ; et al.	2009-02-05
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20080312157 - Levy; Odile Esther ; et al.	2008-12-18
Amylin Family Polypeptide-6 (Afp-6) Analogs and Methods of Making and Using Them App 20080207501 - Erickson; Mary ; et al.	2008-08-28
Aryl N-cyanoguanidines And Methods Related Thereto App 20080032981 - Ghosh; Soumitra S. ; et al.	2008-02-07
Aryl N-cyanoguanidines and methods related thereto Grant 7,230,132 - Ghosh , et al. June 12, 2	2007-06-12
Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass App 20070021496 - Terkeltaub; Robert ; et al.	2007-01-25
Hybrid polypeptides with selectable properties App 20060293232 - Levy; Odile Esther ; et al.	2006-12-28
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same App 20060135747 - Levy; Odile Esther ; et al.	2006-06-22
Pancreatic polypeptide family motifs and polypeptides comprising the same App 20060094653 - Levy; Odile Esther ; et al.	2006-05-04
Hybrid polypeptides with selectable properties App 20060094652 - Levy; Odile Esther ; et al.	2006-05-04
Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass Grant 7,005,274 - Terkeltaub , et al. February 28, 2	2006-02-28
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 7,001,729 - Anderson , et al. February 21, 2	2006-02-21
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto App 20060004093 - Ghosh; Soumitra S. ; et al.	2006-01-05
Compounds for inhibiting insulin secretion and methods related thereto App 20060004062 - Pei; Yazhong ; et al.	2006-01-05
Compounds for inhibiting insulin secretion and methods related thereto Grant 6,958,352 - Pei , et al. October 25, 2	2005-10-25
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto Grant 6,936,638 - Ghosh , et al. August 30, 2	2005-08-30
Aryl N-cyanoguanidines and methods related thereto App 20050182057 - Ghosh, Soumitra S. ; et al.	2005-08-18
Aryl N-cyanoguanidines and methods related thereto Grant 6,927,218 - Ghosh , et al. August 9, 2	2005-08-09
Cobalt-porphyrin complexes and use thereof as an anti-obesity agent App 20050148768 - Szabo, Tomas R. ; et al.	2005-07-07
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. Grant 6,906,175 - Anderson , et al. June 14, 2	2005-06-14
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,902,908 - Anderson , et al. June 7, 2	2005-06-07
Cobalt-porphyrin complexes and use thereof as an anti-obesity agent Grant 6,900,197 - Szabo , et al. May 31, 2	2005-05-31
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Grant 6,887,670 - Anderson , et al. May 3, 2	2005-05-03
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050064530 - Anderson, Christen M. ; et al.	2005-03-24
Method of targeting conjugate molecules to mitochondria Grant 6,867,197 - Davis , et al. March 15, 2	2005-03-15
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050019835 - Anderson, Christen M. ; et al.	2005-01-27
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050003352 - Anderson, Christen M. ; et al.	2005-01-06
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Ligands And Screening Assays Therefor App 20050003353 - Anderson, Christen M. ; et al.	2005-01-06
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto App 20040198777 - Ghosh, Soumitra S. ; et al.	2004-10-07
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto App 20040192740 - Ghosh, Soumitra S. ; et al.	2004-09-30
Targets for therapeutic intervention identified in the mitochondrial proteome App 20040101874 - Ghosh, Soumitra S. ; et al.	2004-05-27
Aryl N-cyanoguanidines and methods related thereto App 20040067987 - Ghosh, Soumitra S. ; et al.	2004-04-08
Compounds for inhibiting insulin secretion and methods related thereto App 20040044049 - Pei, Yazhong ; et al.	2004-03-04
Mitochondria protecting agents for treating mitochondria associated diseases App 20030176448 - Ghosh, Soumitra S. ; et al.	2003-09-18
Proteomic determination of protein nitrotyrosine modifications using mass spectrometry App 20030165983 - Gibson, Bradford W. ; et al.	2003-09-04
Diagnostic and therapeutic compositions for alzheimer's disease App 20030087858 - Herrnstadt, Corinna ; et al.	2003-05-08
Aryl-N-cyanoguanidines and methods related thereto App 20030045556 - Ghosh, Soumitra S. ; et al.	2003-03-06
Compositions And Methods For Identifying Agents That Alter Mitochondrial Permeability Transition Pores App 20030044776 - DYKENS, JAMES A. ; et al.	2003-03-06
Mitochondria protecting agents for treating mitochondria associated diseases Grant 6,511,966 - Ghosh , et al. January 28, 2	2003-01-28
Production Of Adenine Nucleotide Translocator (ant), Novel Ant Lgands And Screening Assays Therrfor App 20020177185 - ANDERSON, CHRISTEN M. ; et al.	2002-11-28
Compounds for altering mitochondrial function and cellular responses App 20020173543 - Pei, Yazhong ; et al.	2002-11-21
Cobalt-porphyrin complexes and use thereof as an anti-obesity agent App 20020165216 - Szabo, Tomas R. ; et al.	2002-11-07
Inhibition of mitochondrial calcium/sodium antiporter App 20020082193 - Anderson, Christen M. ; et al.	2002-06-27
Mitochondria protecting agents for treating mitochondria associated diseases App 20020068750 - Ghosh, Soumitra S. ; et al.	2002-06-06
Mitochondria protecting agents for treating mitochondria associated diseases App 20020065298 - Ghosh, Soumitra S. ; et al.	2002-05-30
Diagnostic Method Based On Quantification Of Extramitochondrial Dna App 20020064773 - HERRNSTADT, CORINNA ; et al.	2002-05-30
Mitochondria protecting agents for treating mitochondria associated diseases App 20020065299 - Ghosh, Soumitra S. ; et al.	2002-05-30
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor App 20020012992 - Anderson, Christen M. ; et al.	2002-01-31
Mitochondria protecting agents for treating mitochondria associated diseases App 20020010195 - Ghosh, Soumitra S. ; et al.	2002-01-24
Compositions and methods for assaying subcellular conditions and processes using energy transfer Grant 6,323,039 - Dykens , et al. November 27, 2	2001-11-27
Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor App 20010044144 - Anderson, Christen M. ; et al.	2001-11-22
End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids Grant 5,478,893 - Ghosh , et al. December 26, 1	1995-12-26
End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids Grant 5,237,016 - Ghosh , et al. August 17, 1	1993-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.